|
Volumn 21, Issue 5, 2012, Pages 598-600
|
Opening a New GATAway for Treating KRAS-Driven Lung Tumors
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BORTEZOMIB;
FASUDIL;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
K RAS PROTEIN;
RHO FACTOR;
TRANSCRIPTION FACTOR GATA 2;
TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6;
CANCER INHIBITION;
CELL PROLIFERATION;
CELL VIABILITY;
GENE EXPRESSION;
GENE INTERACTION;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
NONHUMAN;
ONCOGENE K RAS;
PRIORITY JOURNAL;
RNA INTERFERENCE;
SHORT SURVEY;
|
EID: 84861389726
PISSN: 15356108
EISSN: 18783686
Source Type: Journal
DOI: 10.1016/j.ccr.2012.04.032 Document Type: Short Survey |
Times cited : (9)
|
References (10)
|